{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:35:23Z","timestamp":1772084123037,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 20SWAQK22"],"award-info":[{"award-number":["No. 20SWAQK22"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04167-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:25:47Z","timestamp":1751383547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and evaluation of cepharanthine-\u03b2-cyclodextrin inclusion complex oral tablets for prevention and treatment of COVID-19 lung injury"],"prefix":"10.1038","volume":"15","author":[{"given":"Di","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuona","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4167_CR1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1248\/bpb.b24-00038","volume":"47","author":"Y Kiba","year":"2024","unstructured":"Kiba, Y., Tanikawa, T. & Kitamura, M. Ciclesonide inhibits SARS-CoV-2 Papain-Like protease in vitro. Biol. Pharm. Bull. 47, 965\u2013966 (2024).","journal-title":"Biol. Pharm. Bull."},{"key":"4167_CR2","doi-asserted-by":"crossref","unstructured":"Dl, G. How to understand the overlap of long COVID, chronic fatigue syndrome\/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes. Semin. Arthritis Rheum. 67  (2024).","DOI":"10.1016\/j.semarthrit.2024.152455"},{"key":"4167_CR3","doi-asserted-by":"publisher","first-page":"210185","DOI":"10.1183\/16000617.0185-2021","volume":"31","author":"D Montani","year":"2022","unstructured":"Montani, D. et al. Post-acute COVID-19 syndrome. Eur. Respiratory Rev. 31, 210185 (2022).","journal-title":"Eur. Respiratory Rev."},{"key":"4167_CR4","doi-asserted-by":"crossref","unstructured":"Adjaye-Gbewonyo, D., Vahratian, A., Perrine, C. G. & Bertolli, J. Long COVID in adults: united States, 2022. NCHS Data Brief 1\u20138 (2023).","DOI":"10.15620\/cdc:132417"},{"key":"4167_CR5","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1038\/s41467-022-33825-5","volume":"13","author":"OPO Nevalainen","year":"2022","unstructured":"Nevalainen, O. P. O. et al. Effect of Remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat. Commun. 13, 6152 (2022).","journal-title":"Nat. Commun."},{"key":"4167_CR6","doi-asserted-by":"crossref","unstructured":"Ms, D. et al. Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent long COVID symptoms in an observational cohort study. J. Med. Virol. 96  (2024).","DOI":"10.1002\/jmv.29333"},{"key":"4167_CR7","doi-asserted-by":"publisher","first-page":"e074572","DOI":"10.1136\/bmj-2022-074572","volume":"381","author":"Y Xie","year":"2023","unstructured":"Xie, Y., Choi, T. & Al-Aly, Z. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ 381, e074572 (2023).","journal-title":"BMJ"},{"key":"4167_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12906-024-04489-z","volume":"24","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Cepharanthine synergistically promotes Methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein\/glucocorticoid receptor translocation. BMC Complement. Med. Ther. 24, 186 (2024).","journal-title":"BMC Complement. Med. Ther."},{"key":"4167_CR9","unstructured":"S, K. et al. [Clinical efficacy of Cepharanthin(R)for Radiotherapy-Induced Leukopenia - A nationwide, multicenter, and observational study]. Gan Kagaku Ryoho Cancer Chemother. 43  (2016)."},{"key":"4167_CR10","doi-asserted-by":"publisher","first-page":"113832","DOI":"10.1016\/j.celrep.2024.113832","volume":"43","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. The genome of Stephania Japonica provides insights into the biosynthesis of cepharanthine. Cell. Rep. 43, 113832 (2024).","journal-title":"Cell. Rep."},{"key":"4167_CR11","doi-asserted-by":"crossref","unstructured":"J, Z. et al. Cepharanthine attenuates cerebral ischemia\/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12\/15-LOX signaling. Biomed. Pharmacother. Biomed. Pharmacother. 127 (2020).","DOI":"10.1016\/j.biopha.2020.110151"},{"key":"4167_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10753-013-9734-8","volume":"37","author":"H Huang","year":"2014","unstructured":"Huang, H. et al. Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models. Inflammation 37, 235\u2013246 (2014).","journal-title":"Inflammation"},{"key":"4167_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tiv.2016.03.010","volume":"34","author":"KR Paudel","year":"2016","unstructured":"Paudel, K. R., Karki, R. & Kim, D. W. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Toxicol. Vitro. 34, 16\u201325 (2016).","journal-title":"Toxicol. Vitro"},{"key":"4167_CR14","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.intimp.2011.08.003","volume":"11","author":"T Uto","year":"2011","unstructured":"Uto, T., Nishi, Y., Toyama, M., Yoshinaga, K. & Baba, M. Inhibitory effect of cepharanthine on dendritic cell activation and function. Int. Immunopharmacol. 11, 1932\u20131938 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"4167_CR15","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1080\/13880209.2017.1328446","volume":"55","author":"Y Deng","year":"2017","unstructured":"Deng, Y., Wu, W., Ye, S., Wang, W. & Wang, Z. Determination of cepharanthine in rat plasma by LC-MS\/MS and its application to a Pharmacokinetic study. Pharm. Biol. 55, 1775\u20131779 (2017).","journal-title":"Pharm. Biol."},{"key":"4167_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1208\/s12249-021-02161-0","volume":"22","author":"P Gao","year":"2021","unstructured":"Gao, P. et al. Correction to: Preparation and evaluation of Self-emulsifying drug delivery system (SEDDS) of cepharanthine. AAPS PharmSciTech. 22, 255 (2021).","journal-title":"AAPS PharmSciTech"},{"key":"4167_CR17","doi-asserted-by":"publisher","first-page":"132344","DOI":"10.1016\/j.ijbiomac.2024.132344","volume":"270","author":"W Feng","year":"2024","unstructured":"Feng, W. et al. Direct electrospinning for producing multiple activity nanofibers consisting of aggregated luteolin\/hydroxypropyl-gamma-cyclodextrin inclusion complex. Int. J. Biol. Macromol. 270, 132344 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"4167_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/ijms20030642","volume":"20","author":"SB Carneiro","year":"2019","unstructured":"Carneiro, S. B. et al. Cyclodextrin\u2013Drug inclusion complexes: in vivo and in vitro approaches. Int. J. Mol. Sci. 20, 642 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"4167_CR19","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1208\/s12249-011-9690-2","volume":"12","author":"PJ Sal\u00fastio","year":"2011","unstructured":"Sal\u00fastio, P. J. et al. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. AAPS PharmSciTech. 12, 1276 (2011).","journal-title":"AAPS PharmSciTech"},{"key":"4167_CR20","doi-asserted-by":"crossref","unstructured":"Conceicao, J., Adeoye, O., Cabral-Marques, H. M. & Lobo, J. M. S. Cyclodextrins as drug carriers in pharmaceutical technology: the state of the Art. Current Pharm. Design 24, 1405\u20131433 .","DOI":"10.2174\/1381612824666171218125431"},{"key":"4167_CR21","doi-asserted-by":"crossref","unstructured":"Concei\u00e7\u00e3o, J., Adeoye, O., Cabral-Marques, H. M., & Lobo, J. M. S. Cyclodextrins as excipients in tablet formulations. Drug Discov. Today 23  (2018).","DOI":"10.1016\/j.drudis.2018.04.009"},{"key":"4167_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10847-016-0600-9","volume":"84","author":"T Darekar","year":"2016","unstructured":"Darekar, T. et al. Characterization and in vivo evaluation of lacidipine inclusion complexes with \u03b2-cyclodextrin and its derivatives. J. Incl. Phenom. Macrocycl. Chem. 84, 225\u2013235 (2016).","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"4167_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12247-019-09397-1","volume":"15","author":"SY Singh","year":"2020","unstructured":"Singh, S. Y., Salwa, Shirodkar, R. K., Verma, R. & Kumar, L. Enhancement in dissolution rate of Atorvastatin trihydrate calcium by formulating its porous tablet using sublimation technique. J. Pharm. Innov. 15, 498\u2013520 (2020).","journal-title":"J. Pharm. Innov."},{"key":"4167_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jcis.2020.11.072","volume":"585","author":"F Topuz","year":"2021","unstructured":"Topuz, F., Kilic, M. E., Durgun, E. & Szekely, G. Fast-dissolving antibacterial nanofibers of cyclodextrin\/antibiotic inclusion complexes for oral drug delivery. J. Colloid Interface Sci. 585, 184\u2013194 (2021).","journal-title":"J. Colloid Interface Sci."},{"key":"4167_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3390\/molecules27092745","volume":"27","author":"J Li","year":"2022","unstructured":"Li, J. et al. Bioavailability enhancement of cepharanthine via pulmonary administration in rats and its therapeutic potential for pulmonary fibrosis associated with COVID-19 infection. Molecules 27, 2745 (2022).","journal-title":"Molecules"},{"key":"4167_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.lwt.2017.08.041","volume":"86","author":"S Ho","year":"2017","unstructured":"Ho, S., Thoo, Y. Y., Young, D. J. & Siow, L. F. Inclusion complexation of Catechin by \u03b2-cyclodextrins: characterization and storage stability. LWT 86, 555\u2013565 (2017).","journal-title":"LWT"},{"key":"4167_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13065-018-0395-4","volume":"12","author":"SK Upadhyay","year":"2018","unstructured":"Upadhyay, S. K. & Ali, S. M. Molecular recognition of Flunarizine dihydrochloride and \u03b2-cyclodextrin inclusion complex by NMR and computational approaches. Chem. Cent. J. 12, 33 (2018).","journal-title":"Chem. Cent. J."},{"key":"4167_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molliq.2018.02.131","volume":"259","author":"V Suvarna","year":"2018","unstructured":"Suvarna, V., Thorat, S., Nayak, U., Sherje, A. & Murahari, M. Host-guest interaction study of Efavirenz with hydroxypropyl\u2013\u03b2\u2013cyclodextrin and l\u2013arginine by computational simulation studies: Preparation and characterization of supramolecular complexes. J. Mol. Liq. 259, 55\u201364 (2018).","journal-title":"J. Mol. Liq."},{"key":"4167_CR29","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s10904-018-0809-8","volume":"28","author":"S Amiri","year":"2018","unstructured":"Amiri, S. & Nalbandi, B. Improve solubility and bioavailability of silver sulfadiazine via formation of inclusion complex by cyclodextrin. J. Inorg. Organomet. Polym. 28, 1764\u20131774 (2018).","journal-title":"J. Inorg. Organomet. Polym."},{"key":"4167_CR30","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/acs.jpcb.5b11317","volume":"120","author":"MI Sancho","year":"2016","unstructured":"Sancho, M. I., Andujar, S., Porasso, R. D. & Enriz, R. D. Theoretical and experimental study of inclusion complexes of \u03b2-Cyclodextrins with chalcone and 2\u2019,4\u2019-Dihydroxychalcone. J. Phys. Chem. B 120, 3000\u20133011 (2016).","journal-title":"J. Phys. Chem. B"},{"key":"4167_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.foodhyd.2019.01.011","volume":"91","author":"M Quilaqueo","year":"2019","unstructured":"Quilaqueo, M. et al. Inclusion of Piperine in \u03b2-cyclodextrin complexes improves their bioaccessibility and in vitro antioxidant capacity. Food Hydrocoll. 91, 143\u2013152 (2019).","journal-title":"Food Hydrocoll."},{"key":"4167_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ps.5138","volume":"75","author":"JG Galv\u00e3o","year":"2019","unstructured":"Galv\u00e3o, J. G. et al. Lippia gracilis essential oil in \u03b2-cyclodextrin inclusion complexes: an environmentally safe formulation to control Aedes aegypti larvae. Pest Manag. Sci. 75, 452\u2013459 (2019).","journal-title":"Pest Manag. Sci."},{"key":"4167_CR33","doi-asserted-by":"publisher","first-page":"111739","DOI":"10.1016\/j.indcrop.2019.111739","volume":"140","author":"H Cui","year":"2019","unstructured":"Cui, H., Zhang, C., Li, C. & Lin, L. Preparation and antibacterial activity of Litsea cubeba essential oil\/dandelion polysaccharide nanofiber. Ind. Crops Prod. 140, 111739 (2019).","journal-title":"Ind. Crops Prod."},{"key":"4167_CR34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/coatings10090850","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. \u03b2-Cyclodextrin inclusion complex containing Litsea cubeba essential oil: preparation, optimization, physicochemical, and antifungal characterization. Coatings 10, 850 (2020).","journal-title":"Coatings"},{"key":"4167_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","volume":"59","author":"ME Brewster","year":"2007","unstructured":"Brewster, M. E. & Loftsson, T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv Rev. 59, 645\u2013666 (2007).","journal-title":"Adv. Drug Deliv Rev."},{"key":"4167_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.supflu.2010.05.028","volume":"55","author":"CW Lee","year":"2010","unstructured":"Lee, C. W. et al. Preparation of bitter taste masked Cetirizine dihydrochloride\/\u03b2-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. J. Supercrit. Fluids. 55, 348\u2013357 (2010).","journal-title":"J. Supercrit. Fluids"},{"key":"4167_CR37","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1002\/jps.22539","volume":"100","author":"M Stojanov","year":"2011","unstructured":"Stojanov, M., Wimmer, R. & Larsen, K. L. Study of the inclusion complexes formed between Cetirizine and \u03b1-, \u03b2-, and \u03b3-cyclodextrin and evaluation on their taste-masking properties. J. Pharm. Sci. 100, 3177\u20133185 (2011).","journal-title":"J. Pharm. Sci."},{"key":"4167_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1141-8","volume":"15","author":"KC Navegantes","year":"2017","unstructured":"Navegantes, K. C. et al. Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J. Transl Med. 15, 1\u201321 (2017).","journal-title":"J. Transl Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04167-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:25:49Z","timestamp":1751383549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04167-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04167-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study protocol was approved by the Institution of Animal Care and Use Committee, Academy of Military Medical Science (IACUC-DWZX-2024-P626, Beijing, China). All animal experiments were complied with the ARRIVE guidelines, and were carried out in accordance with the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"20989"}}